For research use only
| Cat No. | ABC-SC2073 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | PBMC |
| Disease | Amyotrophic Lateral Sclerosis |
| Storage | Liquid Nitrogen |
Cell Type: iPSC; Primary Tissue: PBMC; Disease: Amyotrophic Lateral Sclerosis(ALS).
HighQC™ Human IPSC From PBMC-ALS is a disease-specific human induced pluripotent stem cell (iPSC) line derived from peripheral blood mononuclear cells (PBMCs) of a donor diagnosed with Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. The cells preserve pluripotency for ALS-related neural mechanism exploration.They retain the fundamental capacity for trilineage differentiation into cell types of all three germ layers—ectoderm, mesoderm, and endoderm. Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC From PBMC-ALS, HighQC™ hiPSC ALS PBMC, hiPSC-ALS, HighQC™ Human Induced Pluripotent Stem Cells From Peripheral Blood Mononuclear Cells-Amyotrophic Lateral Sclerosis |
| Species | Human |
| Cat.No | ABC-SC2073 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | PBMC |
| Disease | Amyotrophic Lateral Sclerosis |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human IPSC From PBMC-ALS provides a patient-specific model for studying motor neuron disease. Its pluripotent capacity enables directed differentiation into motor neurons, the primary affected cell type, facilitating research on neurodegeneration mechanisms and disease progression. This system supports the generation of neural organoids for modeling ALS pathology and serves as a platform for high-throughput drug screening to identify potential neuroprotective compounds.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).